Page last updated: 2024-08-16

technetium tc 99m sestamibi and su 11248

technetium tc 99m sestamibi has been researched along with su 11248 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balakrishnar, B; Bennink, RJ; Daali, Y; Eechoute, K; Gurney, H; Huitema, AD; Kam, BL; Kloth, JS; Klümpen, HJ; Mathijssen, RH; Samer, CF; Schellens, JH; Wong, M; Yu, H; Zwinderman, AH1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and su 11248

ArticleYear
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biotransformation; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Midazolam; Middle Aged; Phenotype; Prospective Studies; Pyrroles; Radiopharmaceuticals; Sunitinib; Technetium Tc 99m Sestamibi

2014